Agoracom Blog Home

Posts Tagged ‘datametrex’

Datametrex $DM.ca Reports Record Quarterly Financial Results

Posted by AGORACOM-JC at 7:13 AM on Friday, August 28th, 2020
http://www.smallcapepicenter.com/DM%20square.png
  • From the beginning of June, the Company started to generate revenues from selling of COVID-19 test kits, and its traditional cyber security AI business expanded.
  • This attributed to record quarterly revenue of $1.9M with a greatly improved cash position.
  • Company’s revenue increased by 419% in Q2 compared to the same period of last year.
  • Company’s cash position improved significantly, $577,998 compared to $119,675 at the end of 2019.

TORONTO, Aug. 27, 2020 — Datametrex AI Limited (the “Company” or “Datametrex”) (TSXV: DM, FSE: D4G, OTC: DTMXF) is pleased to announce record second quarter 2020 (“Q2”) financial and operating results. All currency is in Canadian dollars, unless otherwise stated. All results are reported on a 100% basis.

From the beginning of June, the Company started to generate revenues from selling of COVID-19 test kits, and its traditional cyber security AI business expanded. This attributed to record quarterly revenue of $1.9M with a greatly improved cash position.

The company’s revenue increased by 419% in Q2 compared to the same period of last year. The Company’s cash position improved significantly, $577,998 compared to $119,675 at the end of 2019. The net loss improved with a decrease by 17% ($868,478) compared ($1,011,962) to the same period of last year. There was a $573,250 option issuance expense and $185,078 Depreciation and Amortization expense, which are non-cash based expenses.

Excluding these expenses, the Company was close to break-even. This is reflected in adjusted EBITDA. The Adjusted EBITDA showed a significant improvement. decreasing by 775%, ($96,126) compared to ($841,500) in the same period of last year. 

“In Q2 2020, the Company achieved multiple key milestones, a significant increase in gross revenue and improvement in its cash position. This positive outcome was a direct result of our quick response in implementing a plan to begin selling test kits as result of the global impact of the COVID-19 virus. This resulted in a substantial improvement to the bottom line,” says Marshall Gunter, CEO of the Company.

Outlook

The Company has a number of potential contracts that it is pursuing and anticipates it will have answers on in Q3. Datametrex is in final stages of a COVID-19 test kit supply agreement with a U.S. Government agency. Under the terms of the agreement, the Company will supply 120,000 1copy™ COVID-19 qPCR Multi kit every two weeks for six months.

Datametrex is in final stages of a COVID-19 testing supply agreement to test all landed passenger and crew from cruise ships making a port of call for the Caribbean country of Antigua using the 1copy™ COVID-19 qPCR Multi kit. Under the terms of the agreement, the Company will supply around 6,000 test kits per day and will also supply the latest Polymerase Chain Reaction (PCR) machine (qTOWER3 PCR) to reduce inspection time and lead time. Before landing at the cruise terminal, the cruise line will distribute alphanumeric labels to each passenger and present labels to technicians along with boarding passes and passports at the COVID-19 testing and temperature testing station set up in a passageway exiting the ship.

Datametrex is also in different stages of negotiation on supply agreements for both COVID-19 test kits along with suppling the latest PCR machines (qTOWER3 PCR) with other countries worldwide for mining, education institutions, health agencies, film and TV productions and cruise industry.

Highlights for Q2 2020

  • Recognized revenue of $2.7 million for the six-month 2020 period compared to $875 thousand in same period 2019, of which $1.9 million was earned in the second quarter.
  • The Company started securing and delivering purchase orders of COVID-19 test kits and generated $1.4 million COVID-19 related revenue in Q2 2020 compared to $0 in Q2 2019.
  • The Company has received $1.8 million from the exercise of share purchase warrants and options.
  • The Company introduced Nexalogy’s Social Media Automated Reporting Technologies.
  • The Company completed the second phase of a multi-phase R&D program through the Department of National Defence’s Innovation for Defence Excellence and Security IDEaS program.

Financial Highlights

The following table summarizes revenue, net loss and EBITDA* and Adjusted EBITDA* for the three and six months ended June 30, 2020 and 2019.

 Three months
ended June 30,
   Six months
ended June 30,
  
 2020  2019  % 2020  2019  %
 $ $   $ $   
 Revenue   1,954,394  376,518  419%    2,763,796  875,083  216%
 Net loss    (868,478) (1,011,962) 17%   (1,590,239) (1,916,754) 21%
 EBITDA*    (669,376) (830,227) 24%   (1,197,679) (1,553,756) 30%
 EBITDA per share*        (0.003) (0.004) 73%         (0.005) (0.007) 71%
 Adjusted EBITDA*      (96,126) (841,500) 775%      (353,429) (1,553,756) 340%
 Adjusted EBITDA per share*      (0.0004) (0.004) 10%         (0.001) (0.007) 21%

* Note: EBITDA ( non- IFRS measures) is calculated as Net Loss adjusted for 1. Income taxes, 2. Depreciation and amortization, and 3. Interest and accretion. Adjusted EBITDA (non-IFRS measures) is calculated as EBITFA adjusted for share based compensation.

Non-IFRS financial measures do not have standardized meaning prescribed by IFRS and are therefore unlikely to be comparable to similar measures presented by other companies. Specific items may only be relevant in certain periods. For reconciliation of non-IFRS financial measures please refer to the Company’s Management Discussion and Analysis for the six months ended June 30, 2020.

The Company’s Financial Statements and Management Discussion & Analysis (“MD&A”) are at SEDAR at www.sedar.com.

About Datametrex

Datametrex AI Limited is a technology-focused company with exposure to Artificial Intelligence and Machine Learning through its wholly owned subsidiary, Nexalogy (www.nexalogy.com). Datametrex’s mission is to provide tools that support companies in fulfilling their operational Health and Safety goals with predictive and preventive technologies. By working with companies to set a new standard of protocols through Artificial Intelligence and health diagnostics, the Company provides progressive solutions to support the supply chain.

Additional information on Datametrex is available at www.datametrex.com.

For further information, please contact:

Marshall Gunter – CEO
Phone: (514) 295-2300
Email: [email protected]

Forward-Looking Statements

This news release contains “forward-looking information” within the meaning of applicable securities laws. All statements contained herein that are not clearly historical in nature may constitute forward-looking information. In some cases, forward-looking information can be identified by words or phrases such as “may”, “will”, “expect”, “likely”, “should”, “would”, “plan”, “anticipate”, “intend”, “potential”, “proposed”, “estimate”, “believe” or the negative of these terms, or other similar words, expressions and grammatical variations thereof, or statements that certain events or conditions “may” or “will” happen, or by discussions of strategy.

Readers are cautioned to consider these and other factors, uncertainties and potential events carefully and not to put undue reliance on forward-looking information. The forward-looking information contained herein is made as of the date of this press release and is based on the beliefs, estimates, expectations and opinions of management on the date such forward-looking information is made. The Company undertakes no obligation to update or revise any forward-looking information, whether as a result of new information, estimates or opinions, future events or results or otherwise or to explain any material difference between subsequent actual events and such forward-looking information, except as required by applicable law.

Datametrex $DM.ca Starts Selling #COVID19 Test Kits to the Canadian Film Industry With First Contract

Posted by AGORACOM-JC at 12:34 PM on Wednesday, August 26th, 2020
  • Company expands its AI technologies and COVID-19 screening solutions by expanding into the Film and Television Industry in Vancouver, British Columbia
  • ompany also signed the first contract with a Vancouver based production company, Bob Industries LLC, to provide COVID-19 test kits and completed its first COVID-19 testing for the production company
  • With these potential partnerships and the launch of the new COVID-19 pre-screening and screening tools, Datametrex enters the film and television industry

TORONTO, Aug. 26, 2020 — Datametrex AI Limited (the “Company” or “Datametrex”) (TSXV: DM, FSE: D4G, OTC: DTMXF) expands its AI technologies and COVID-19 screening solutions by expanding into the Film and Television Industry in Vancouver, British Columbia.

The Company also signed the first contract with a Vancouver based production company, Bob Industries LLC, to provide COVID-19 test kits and completed its first COVID-19 testing for the production company. With these potential partnerships and the launch of the new COVID-19 pre-screening and screening tools, Datametrex enters the film and television industry.

Vancouver is the third largest production centre in North America, worth CDN $3.2 Billion during 2018/19, according to Creative BC. British Columbia is home to several world-class Film and TV studios, includingBridge Studios, Mammoth Studios, Vancouver Film Studios, North Shore Studios, Ironwood Studios, Canadian Motion Picture Park, and The Crossing Studios.

These facilities produce, on average, approximately 65+ movies and 55+ TV series annually, as well as hundreds of other filming days for commercials, TV pilots and other features. This industry generates over 42,000 direct and indirect jobs in Film and TV production, with more than 80 percent located in Metro Vancouver. British Columbia is world-renowned as a versatile and dependable hub for motion picture production.

Total film and TV production in Canada represent $8.92 Billion in production volume and full-time equivalent jobs represent 179,000 workers. When production was shut down in March 2020, Vancouver and area had 46 productions filming and that does not include the TV commercial market. Each of the productions would have a minimum of 100-person film crew.

As the current pandemic continues to impact our world, and with health risks in the film industry, Datametrex is contributing to the health and safety of film organizations. An article that CNBC posted on August 22, 2020, mentions that Solstice Studios is moving a feature film production to Canada, even though it was supposed to film in the U.S., because of available coronavirus testing, making Canada an attractive location for filming.1

This shows that Canada can be an advocate for the Film industry, as we have testing and labs already set up throughout. Additionally, Canada has far fewer instances of coronavirus. The country reported an average of less than 400 new coronavirus cases per day over the past week, compared with more than 46,400 in the U.S., according to data compiled by Johns Hopkins University.

“With the changing nature of the pandemic and worldwide regulations, it is essential that the solutions we develop at Datametrex are flexible and accurate,” said Marshall Gunter, CEO of Datametrex. “With our pre-screening and screening tools, this industry can resume and provide us with the much needed entertainment that this newly indoor, online-based culture requires.”

These tools were developed as a direct response to customer needs and the ever-changing physical distancing recommendations, safety guidelines, and workplace flexibility initiatives being observed across North America and around the globe. Datametrex anticipates that it will have little or no upfront costs associated with importing and selling these test kits.

About Datametrex
Datametrex AI Limited is a technology-focused with exposure to Artificial Intelligence and Machine Learning through its wholly-owned subsidiary, Nexalogy (www.nexalogy.com). Datametrex’s mission is to provide tools that support companies in fulfilling their operational goals, including Health and Safety, with predictive and preventive technologies. By working with companies to set a new standard of protocols through Artificial Intelligence and health diagnostics, Company provides progressive solutions to support the supply chain. Additional information on Datametrex is available at www.datametrex.com.

For further information, please contact:
Marshall Gunter – CEO
Phone: (514) 295-2300
Email:  [email protected]

Neither the TSX Venture Exchange nor it’s Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Forward-Looking Statements
This news release contains “forward-looking information” within the meaning of applicable securities laws. All statements contained herein that are not historical may constitute forward-looking information. In some cases, forward-looking information can be identified by words or phrases such as “may”, “will”, “expect”, “likely”, “should”, “would”, “plan”, “anticipate”, “intend”, “potential”, “proposed”, “estimate”, “believe” or the negative of these terms, or other similar words, expressions and grammatical variations thereof, or statements that certain events or conditions “may” or “will” happen, or by discussions of strategy. Readers are cautioned to consider these and other factors, uncertainties and potential events carefully and not to put undue reliance on forward-looking information. The forward-looking information contained herein is made as of the date of this press release and is based on the beliefs, estimates, expectations and opinions of management on the time such forward-looking information is made. Company undertakes no obligation to update or revise any forward-looking information, whether as a result of new information, estimates or opinions, future events or results or otherwise or to explain any material difference between subsequent actual events and such forward-looking information, except as required by applicable law.

Datametrex $DM.ca Signs Another $250,000 Sales Contract With #LOTTE

Posted by AGORACOM-JC at 2:37 PM on Thursday, August 20th, 2020
  • Entered into additional agreement for providing IT solution and services totalling approximately $250,000 with two divisions of LOTTE companies, LOTTE Home Shopping and LOTTE Property and Development
  • Datametrex is continuously working with the various divisions of LOTTE and has demonstrated to be a quality, reliable, and trustworthy AI technology solutions vendor, providing critical optimizations for business structures
  • This relationship is demonstrating that there is an opportunity to grow Datametrex’s footprint within LOTTE’s distinct organizations

TORONTO, Aug. 20, 2020 — Datametrex AI Limited (the “Company” or “Datametrex“) (TSXV: DM, FSE: D4G, OTC: DTMXF) is pleased to announce that it has entered into additional agreement for providing IT solution and services totalling approximately $250,000 with two divisions of LOTTE companies (“LOTTE”), LOTTE Home Shopping and LOTTE Property and Development.

LOTTE Home Shopping aims to provide a creative consumer experience by working with customers to build trust and satisfy their needs. It operates businesses in the areas of television shopping, Internet shopping malls, catalogues, and mobile shopping in South Korea and internationally, including locations in Japan, South Korea, China, Indonesia, and Vietnam.

LOTTE Property & Development operates as a high rise multi-purpose shopping mall and provides the LOTTE World Tower and the LOTTE World Mall with environmentally friendly urban green complex development, operations, and other related services.

Datametrex is continuously working with the various divisions of LOTTE and has demonstrated to be a quality, reliable, and trustworthy AI technology solutions vendor, providing critical optimizations for business structures.  This relationship is demonstrating that there is an opportunity to grow Datametrex’s footprint within LOTTE’s distinct organizations.

“At Datametrex, we continue our efforts to facilitate ground-breaking technologies to companies across the globe. We pride ourselves in providing tools that our clients can use to visualize their customers and stakeholders to make predictive analyses, mitigate risk, and improve their bottom line,” stated Marshall Gunter, CEO of Datametrex.

About LOTTE

LOTTE Group is the fifth-largest conglomerate in Korea with annual revenues of approximately USD 60 billion, consisting of over 90 business divisions. LOTTE is engaged in diverse industries that include hotels, resorts, fast food, beverages, retail, financial services, heavy chemicals, electronics, IT, construction, publishing, confectionary products, and entertainment. Additional information on LOTTE is available at www.lotte.co.kr

About Datametrex

Datametrex AI Limited is a technology focused company with exposure to Artificial Intelligence and Machine Learning through its wholly owned subsidiary, Nexalogy (www.nexalogy.com). Datametrex’s mission is to provide tools that support companies in fulfilling their operational goals, including Health and Safety, with predictive and preventive technologies. By working with companies to set a new standard of protocols through Artificial Intelligence and health diagnostics, the Company provides progressive solutions to support the supply chain. Additional information on Datametrex is available at www.datametrex.com

For further information, please contact:

Marshall Gunter – CEO
Phone: (514) 295-2300
Email: [email protected]

Neither the TSX Venture Exchange nor it’s Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Forward-Looking Statements

This news release contains “forward-looking information” within the meaning of applicable securities laws.  All statements contained herein that are not clearly historical in nature may constitute forward-looking information. In some cases, forward-looking information can be identified by words or phrases such as “may”, “will”, “expect”, “likely”, “should”, “would”, “plan”, “anticipate”, “intend”, “potential”, “proposed”, “estimate”, “believe” or the negative of these terms, or other similar words, expressions and grammatical variations thereof, or statements that certain events or conditions “may” or “will” happen, or by discussions of strategy. Readers are cautioned to consider these and other factors, uncertainties and potential events carefully and not to put undue reliance on forward-looking information. The forward-looking information contained herein is made as of the date of this press release and is based on the beliefs, estimates, expectations and opinions of management on the date such forward-looking information is made. The Company undertakes no obligation to update or revise any forward-looking information, whether as a result of new information, estimates or opinions, future events or results or otherwise or to explain any material difference between subsequent actual events and such forward-looking information, except as required by applicable law.

Datametrex $DM.ca Announces Purchase Orders and Completion of Delivery

Posted by AGORACOM-JC at 8:08 AM on Thursday, August 20th, 2020
  • Announced that it has received a second Purchase Order from Canadian Royalties Inc., a private mining company operating a copper and nickel mine in Nunavik, Quebec
  • This P.O. is for 2,000 tests with 1copy test kits, approximately $200,000 in sales, making the total sales to date approximately $400,000
  • Datametrex has completed delivery to another Canadian mining company for their South America mining site and has completed shipping 30,000 1copy test kits, 30,000 UTMs, a PCR machine, 30,000 RNA extraction kits and an RNA extraction machine
  • Approximate sales from this transaction is $850,000.The Company received its payment in full

TORONTO, Aug. 20, 2020 — Datametrex AI Limited (the “Company” or “Datametrex“) (TSXV: DM, FSE: D4G, OTC: DTMXF) is pleased to announce that it has received a second Purchase Order (“P.O.”) from Canadian Royalties Inc. (“CRI”), a private mining company operating a copper and nickel mine in Nunavik, Quebec. This P.O. is for 2,000 tests with 1copy test kits, approximately $200,000 in sales, making the total sales to date approximately $400,000.

Canadian Royalties is committed to occupational health and safety, and with the help of Datametrex, Canadian Royalties is endeavouring to allow its workforce to continue to operate with less risk. Canadian Royalties has over 1,000 employees at the Nunavik Nickel Project. On average, 400 people live and work on constant rotation at the Project, whether at the EXPO or Deception Bay camps, all on a fly-in / fly-out rotation.

Datametrex has completed delivery to another Canadian mining company for their South America mining site and has completed shipping 30,000 1copy test kits, 30,000 UTMs, a PCR machine, 30,000 RNA extraction kits and an RNA extraction machine. Approximate sales from this transaction is $850,000.The Company received its payment in full.

“We are thrilled to be able to support the operations of these mining companies as they endeavour to protect their employees and minimize the dangers, risks, and impacts that COVID-19 has brought,” stated Marshall Gunter, CEO of Datametrex.

About Canadian Royalties Inc.
Canadian Royalties Inc. (“CRI”) is a private mining company based in Montreal that operates a copper and nickel mine in Nunavik (province of Quebec), under the name Nunavik Nickel Project (“Project”). CRI is solely owned by their parent company in China, Jilin Jien Nickel Industry Co., Ltd. Canadian Royalties Inc. will engage the commitment and involvement of all of its employees and contractors to ensure that environmental, health and safety performance objectives are met. Additional information on Canadian Royalties is available at https://www.canadianroyalties.com/

About Datametrex
Datametrex AI Limited is a technology focused company with exposure to Artificial Intelligence and Machine Learning through its wholly owned subsidiary, Nexalogy (www.nexalogy.com). Datametrex’s mission is to provide tools that support companies in fulfilling their operational goals, including Health and Safety, with predictive and preventive technologies. By working with companies to set a new standard of protocols through Artificial Intelligence and health diagnostics, the Company provides progressive solutions to support the supply chain. Additional information on Datametrex is available at www.datametrex.com

For further information, please contact:

Marshall Gunter – CEO
Phone: (514) 295-2300
Email: [email protected]

Neither the TSX Venture Exchange nor it’s Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Forward-Looking Statements
This news release contains “forward-looking information” within the meaning of applicable securities laws.  All statements contained herein that are not clearly historical in nature may constitute forward-looking information. In some cases, forward-looking information can be identified by words or phrases such as “may”, “will”, “expect”, “likely”, “should”, “would”, “plan”, “anticipate”, “intend”, “potential”, “proposed”, “estimate”, “believe” or the negative of these terms, or other similar words, expressions and grammatical variations thereof, or statements that certain events or conditions “may” or “will” happen, or by discussions of strategy. Readers are cautioned to consider these and other factors, uncertainties and potential events carefully and not to put undue reliance on forward-looking information. The forward-looking information contained herein is made as of the date of this press release and is based on the beliefs, estimates, expectations and opinions of management on the date such forward-looking information is made. The Company undertakes no obligation to update or revise any forward-looking information, whether as a result of new information, estimates or opinions, future events or results or otherwise or to explain any material difference between subsequent actual events and such forward-looking information, except as required by applicable law.

Datametrex $DM.ca Secures $2.3M Contract

Posted by AGORACOM-JC at 10:07 AM on Thursday, August 13th, 2020
  • Entered into an additional sales agreement for approximately $2.3M with Lotte Home Shopping Co. Ltd., bringing the total gross sales to $3.3M this year so far
  • LOTTE Home Shopping operates large retail stores and department stores in various countries like Japan, South Korea, China, and Vietnam
  • Datametrex is continuously working with the various divisions of LOTTE as a preferred vendor
  • LOTTE Group is the fifth-largest conglomerate in Korea with annual revenues of approximately USD 60 billion, consisting of over 90 business divisions.

TORONTO, Aug. 13, 2020 — Datametrex AI Limited (the “Company” or “Datametrex“) (TSXV: DM, FSE: D4G, OTC: DTMXF) is pleased to announce that it has entered into an additional sales agreement for approximately $2.3M with Lotte Home Shopping Co. Ltd. (“LOTTE”), bringing the total gross sales to $3.3M this year so far.

LOTTE Home Shopping operates large retail stores and department stores in various countries like Japan, South Korea, China, and Vietnam.

Datametrex is continuously working with the various divisions of LOTTE as a preferred vendor. Datametrex has demonstrated to be a quality, reliable, and trustworthy partner, with an opportunity to grow within the 934 companies in the LOTTE family.

“At Datametrex, we continue our efforts to facilitate ground-breaking technologies to companies across the globe. We pride ourselves in providing tools that our clients can use to visualize their customer and stakeholder data in order to make predictive analyses, mitigate risk, and improve their bottom line,” stated Marshall Gunter, CEO of Datametrex.

Datametrex plans to deliver the contract in August with full payment in September 2020.

Datametrex is also pleased to share that the Company has won a tender from LOTTE Property and Development Co. Ltd. for approximately $100K.

About LOTTE Group

LOTTE Group is the fifth-largest conglomerate in Korea with annual revenues of approximately USD 60 billion, consisting of over 90 business divisions. LOTTE is engaged in diverse industries that include hotels, resorts, fast food, beverages, retail, financial services, heavy chemicals, electronics, IT, construction, publishing, confectionary products, and entertainment. Additional information on LOTTE is available at www.lotte.co.kr

About Datametrex

Datametrex AI Limited is a technology focused company with exposure to Artificial Intelligence and Machine Learning through its wholly owned subsidiary, Nexalogy (www.nexalogy.com). Datametrex’s mission is to provide tools that support companies in fulfilling their operational goals, including Health and Safety, with predictive and preventive technologies. By working with companies to set a new standard of protocols through Artificial Intelligence and health diagnostics, the Company provides progressive solutions to support the supply chain. Additional information on Datametrex is available at www.datametrex.com

For further information, please contact:

Marshall Gunter – CEO
Phone: (514) 295-2300
Email: [email protected]

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Forward-Looking Statements

This news release contains “forward-looking information” within the meaning of applicable securities laws.  All statements contained herein that are not clearly historical in nature may constitute forward-looking information. In some cases, forward-looking information can be identified by words or phrases such as “may”, “will”, “expect”, “likely”, “should”, “would”, “plan”, “anticipate”, “intend”, “potential”, “proposed”, “estimate”, “believe” or the negative of these terms, or other similar words, expressions and grammatical variations thereof, or statements that certain events or conditions “may” or “will” happen, or by discussions of strategy. Readers are cautioned to consider these and other factors, uncertainties and potential events carefully and not to put undue reliance on forward-looking information. The forward-looking information contained herein is made as of the date of this press release and is based on the beliefs, estimates, expectations and opinions of management on the date such forward-looking information is made. The Company undertakes no obligation to update or revise any forward-looking information, whether as a result of new information, estimates or opinions, future events or results or otherwise or to explain any material difference between subsequent actual events and such forward-looking information, except as required by applicable law.

Datametrex $DM.ca Secures COVID-19 Antigen Detection Kits

Posted by AGORACOM-JC at 9:10 AM on Wednesday, August 12th, 2020

  • Announced that it has secured rights to sell and distribute South Korean manufacturer PCL, Inc.’s (“PCL”) COV05 COVID19 Rapid Antigen Detection Kits
  • These test kits are suitable for point of care tests. No extra equipment is needed. They are easy to use with over 97% accuracy, and results are available in 5 to 10 minutes
  • Antigen Rapid Diagnosis Kit developed by PCL is a method of fluorescently measuring the presence of a COVID-19 infection

TORONTO, Aug. 12, 2020 — Datametrex AI Limited (the “Company” or “Datametrex”) (TSXV: DM, FSE: D4G, OTC: DTMXF) is pleased to announce that it has secured rights to sell and distribute South Korean manufacturer PCL, Inc.’s (“PCL”) COV05 COVID19 Rapid Antigen Detection Kits. These test kits are suitable for point of care tests. No extra equipment is needed. They are easy to use with over 97% accuracy, and results are available in 5 to 10 minutes.

The Antigen Rapid Diagnosis Kit developed by PCL is a method of fluorescently measuring the presence of a COVID-19 infection. It is an in-vitro diagnostic medicaldevice to detect the SARS-CoV-2 antigen from a person’s oropharyngeal and nasopharyngeal secretions if the specimen contains antigens to SARS-CoV-2, a colored line appears in the T line area.

View the PCL test by clicking the link PCL COVID-19 ANTIBODY TEST – COV0

“According to the manufacturer, PCL, this test can detect antigens of COVID-19 from a swab in the nose or throat and provide results in 10 minutes with over 97% accuracy,” said Marshall Gunter, CEO of Datametrex. “These almost-instant kits can be easily used at home. With the rise of cases in the United States and throughout the world, we at Datametrex believes it is critical to test and protect.”

PCL states that the clinical sensitivity (confirmed the actual positive of the approved person) is 100% and the clinical specificity (confirmed the actual negative of the negative person) is 97.78%. Early detection using rapid tests will also provide further protection to Canada’s front-line workers, especially health care professionals.

The following certifications have been awarded to these PCL Antigen Test Kits: CE Certificate, Korea FDA, FIND Listed, UNGM Supplier. Countries includes the EU, 2 countries in the Middle East- Qatar and UAE, India, Russia, 3 countries in Latin America- Guatemala, Ecuador, and Colombia.

The PCL Antigen Detection kit has the CE Certificate meaning that the manufacturer and products have met EU declaration of standards for health, safety, and environmental protection, allowing this product to be sold within the 22 countries in the European Economic Area.

Worldwide, currently there have been over 19.7M people who have been tested positive for COVID-19 but the actual case count is believed to be higher, as a significant number of asymptomatic people may not have been tested. Even more worrying is that most families have had to wait more than 72 hours for their test results to come back from both public and private labs increasing the possibility of spreading the virus.

Rapid Diagnosis Kit is easy when there are no symptoms even after COVID-19 infection, or when ‘positive’ and ‘negative’ are not evident in tests such as RT-PCR. When an infection occurs, an antigen against COVID-19 is formed in the body after some time, so it is a post-test that is essential as a preventive measure.

The Company is not making any express or implied claims that its product has the ability to eliminate, cure or contain the COVID-19 (or SARS-2 Coronavirus) at this time. Health Canada must approve these COVID-19 test kits before they can be used in Canada. The Company plans to sell these kits in all countries where the kits have been approved for sale.

About Datametrex

Datametrex AI Limited is a technology-focused with exposure to Artificial Intelligence and Machine Learning through its wholly-owned subsidiary, Nexalogy (www.nexalogy.com). Datametrex’s mission is to provide tools that support companies in fulfilling their operational goals, including Health and Safety, with predictive and preventive technologies. By working with companies to set a new standard of protocols through Artificial Intelligence and health diagnostics, Company provides progressive solutions to support the supply chain. Additional information on Datametrex is available at www.datametrex.com.

For further information, please contact:
Marshall Gunter – CEO
Phone: (514) 295-2300
Email: [email protected]

Neither the TSX Venture Exchange nor it’s Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Forward-Looking Statements

This news release contains “forward-looking information” within the meaning of applicable securities laws. All statements contained herein that are not historical may constitute forward-looking information. In some cases, forward-looking information can be identified by words or phrases such as “may”, “will”, “expect”, “likely”, “should”, “would”, “plan”, “anticipate”, “intend”, “potential”, “proposed”, “estimate”, “believe” or the negative of these terms, or other similar words, expressions and grammatical variations thereof, or statements that certain events or conditions “may” or “will” happen, or by discussions of strategy.

Readers are cautioned to consider these and other factors, uncertainties and potential events carefully and not to put undue reliance on forward-looking information. The forward-looking information contained herein is made as of the date of this press release and is based on the beliefs, estimates, expectations and opinions of management on the time such forward-looking information is made. Company undertakes no obligation to update or revise any forward-looking information, whether as a result of new information, estimates or opinions, future events or results or otherwise or to explain any material difference between subsequent actual events and such forward-looking information, except as required by applicable law.

Primary Logo

The Antigen Rapid Diagnosis Kit developed by PCL is a method of fluorescently measuring the presence of a COVID-19 infection. It is an in-vitro diagnostic medicaldevice to detect the SARS-CoV-2 antigen from a person’s oropharyngeal and nasopharyngeal secretions if the specimen contains antigens to SARS-CoV-2, a colored line appears in the T line area.

View the PCL test by clicking the link PCL COVID-19 ANTIBODY TEST – COV0

“According to the manufacturer, PCL, this test can detect antigens of COVID-19 from a swab in the nose or throat and provide results in 10 minutes with over 97% accuracy,” said Marshall Gunter, CEO of Datametrex. “These almost-instant kits can be easily used at home. With the rise of cases in the United States and throughout the world, we at Datametrex believes it is critical to test and protect.”

PCL states that the clinical sensitivity (confirmed the actual positive of the approved person) is 100% and the clinical specificity (confirmed the actual negative of the negative person) is 97.78%. Early detection using rapid tests will also provide further protection to Canada’s front-line workers, especially health care professionals.

The following certifications have been awarded to these PCL Antigen Test Kits: CE Certificate, Korea FDA, FIND Listed, UNGM Supplier. Countries includes the EU, 2 countries in the Middle East- Qatar and UAE, India, Russia, 3 countries in Latin America- Guatemala, Ecuador, and Colombia.

The PCL Antigen Detection kit has the CE Certificate meaning that the manufacturer and products have met EU declaration of standards for health, safety, and environmental protection, allowing this product to be sold within the 22 countries in the European Economic Area.

Worldwide, currently there have been over 19.7M people who have been tested positive for COVID-19 but the actual case count is believed to be higher, as a significant number of asymptomatic people may not have been tested. Even more worrying is that most families have had to wait more than 72 hours for their test results to come back from both public and private labs increasing the possibility of spreading the virus.

Rapid Diagnosis Kit is easy when there are no symptoms even after COVID-19 infection, or when ‘positive’ and ‘negative’ are not evident in tests such as RT-PCR. When an infection occurs, an antigen against COVID-19 is formed in the body after some time, so it is a post-test that is essential as a preventive measure.

The Company is not making any express or implied claims that its product has the ability to eliminate, cure or contain the COVID-19 (or SARS-2 Coronavirus) at this time. Health Canada must approve these COVID-19 test kits before they can be used in Canada. The Company plans to sell these kits in all countries where the kits have been approved for sale.

About Datametrex

Datametrex AI Limited is a technology-focused with exposure to Artificial Intelligence and Machine Learning through its wholly-owned subsidiary, Nexalogy (www.nexalogy.com). Datametrex’s mission is to provide tools that support companies in fulfilling their operational goals, including Health and Safety, with predictive and preventive technologies. By working with companies to set a new standard of protocols through Artificial Intelligence and health diagnostics, Company provides progressive solutions to support the supply chain. Additional information on Datametrex is available at www.datametrex.com.

For further information, please contact:
Marshall Gunter – CEO
Phone: (514) 295-2300
Email: [email protected]

Neither the TSX Venture Exchange nor it’s Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Forward-Looking Statements

This news release contains “forward-looking information” within the meaning of applicable securities laws. All statements contained herein that are not historical may constitute forward-looking information. In some cases, forward-looking information can be identified by words or phrases such as “may”, “will”, “expect”, “likely”, “should”, “would”, “plan”, “anticipate”, “intend”, “potential”, “proposed”, “estimate”, “believe” or the negative of these terms, or other similar words, expressions and grammatical variations thereof, or statements that certain events or conditions “may” or “will” happen, or by discussions of strategy.

Readers are cautioned to consider these and other factors, uncertainties and potential events carefully and not to put undue reliance on forward-looking information. The forward-looking information contained herein is made as of the date of this press release and is based on the beliefs, estimates, expectations and opinions of management on the time such forward-looking information is made. Company undertakes no obligation to update or revise any forward-looking information, whether as a result of new information, estimates or opinions, future events or results or otherwise or to explain any material difference between subsequent actual events and such forward-looking information, except as required by applicable law.

Primary Logo

Datametrex $DM.ca Commenced Rolling Out COVID-19 Screening Solutions in Anticipation of P.O. From Educational Organizations

Posted by AGORACOM-JC at 9:10 AM on Wednesday, August 5th, 2020
  • Commenced rolling out its screening solutions for health and safety in the education sector in anticipation of Purchase Order from schools and international student recruiting agencies by launching of the new COVID-19 pre-screening and screening tools
  • As the current pandemic continues to impact our world, education is one of the most hit industry
  • With schools plan to reopen in September, Datametrex is offering solutions to educational organizations for the health and safety of students, teachers, and administrative staff

TORONTO, Aug. 05, 2020 — Datametrex AI Limited (the “Company” or “Datametrex”) (TSXV: DM, FSE: D4G, OTC: DTMXF) – Through its COVID-19 screening solutions, Datametrex has commenced rolling out its screening solutions for health and safety in the education sector in anticipation of Purchase Order from schools and international student recruiting agencies by launching of the new COVID-19 pre-screening and screening tools.

As the current pandemic continues to impact our world, education is one of the most hit industry. With schools plan to reopen in September, Datametrex is offering solutions to educational organizations for the health and safety of students, teachers, and administrative staff. A recent article by the CBC mentioned that language and private schools are struggling to survive the pandemic because they depend on international students coming into Canada. There are roughly 200 language schools across the country, with 40,000 international students in attendance. With the tools available by Datametrex, these organizations could pre-screen, screen, and report on exposures to decrease the spread and mitigate the risk. (https://www.cbc.ca/news/business/language-schools-covid-foreign-students-1.5668592)

“With schools poised to reopen in Fall, we offer important tool to the education industry. Key is not only opening up the school but also maintaining schools to stay open,” said Marshall Gunter, CEO of Datametrex. “With our pre-screening and screening tools, educational organizations can now provide a safer academic environment to the students and safer workplace to teaching staff with rapid results and trends for COVID-19 in real-time.”

These tools were developed as a direct response to customer needs and the ever-changing physical distancing recommendations, safety guidelines, and workplace flexibility initiatives being observed across North America and around the globe.

About Datametrex
Datametrex AI Limited is a technology-focused with exposure to Artificial Intelligence and Machine Learning through its wholly-owned subsidiary, Nexalogy (www.nexalogy.com). Datametrex’s mission is to provide tools that support companies in fulfilling their operational goals, including Health and Safety, with predictive and preventive technologies. By working with companies to set a new standard of protocols through Artificial Intelligence and health diagnostics, Company provides progressive solutions to support the supply chain. Additional information on Datametrex is available at www.datametrex.com.

For further information, please contact:
Marshall Gunter – CEO
Phone: (514) 295-2300
Email: [email protected]

Neither the TSX Venture Exchange nor it’s Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Forward-Looking Statements

This news release contains “forward-looking information” within the meaning of applicable securities laws. All statements contained herein that are not historical may constitute forward-looking information. In some cases, forward-looking information can be identified by words or phrases such as “may”, “will”, “expect”, “likely”, “should”, “would”, “plan”, “anticipate”, “intend”, “potential”, “proposed”, “estimate”, “believe” or the negative of these terms, or other similar words, expressions and grammatical variations thereof, or statements that certain events or conditions “may” or “will” happen, or by discussions of strategy.

Readers are cautioned to consider these and other factors, uncertainties and potential events carefully and not to put undue reliance on forward-looking information. The forward-looking information contained herein is made as of the date of this press release and is based on the beliefs, estimates, expectations and opinions of management on the time such forward-looking information is made. Company undertakes no obligation to update or revise any forward-looking information, whether as a result of new information, estimates or opinions, future events or results or otherwise or to explain any material difference between subsequent actual events and such forward-looking information, except as required by applicable law.

Datametrex $DM.ca Awarded Contract Extension With #USAirForce

Posted by AGORACOM-JC at 11:32 AM on Friday, July 31st, 2020
  • Successfully awarded a second contract in the United States defense industry, United States Air Force via Wright State Applied Research Corp. on July 29, 2020
  • WSARC is provides contracting, security and research administration services for Wright State Research Institute, the University and the state of Ohio, and will head the U.S. Air Force Academic Partnership and Engagement Experiment (APEX) program

TORONTO, July 31, 2020 – Datametrex AI Limited (the “Company” or “Datametrex“) (TSXV: DM, FSE: D4G) is pleased to announce that it has been successfully awarded a second contract in the United States defense industry, United States Air Force via Wright State Applied Research Corp. (“WSARC”) on July 29, 2020. WSARC is provides contracting, security and research administration services for Wright State Research Institute, the University and the state of Ohio, and will head the U.S. Air Force Academic Partnership and Engagement Experiment (APEX) program.

“This is a great example of renewable business for Datametrex. Getting a one-year contract extension shows that our technology is valued by the client, and marks progress in our plan to expand our mandate with the organization. Datametrex will continue to solidify our position as a trusted solution provider within the U.S. military departments.” says Marshall Gunter, CEO of the Company.

The contract extension continues with the U.S. Air Force researchers at the Air Force Research Laboratory Airman Systems directorate. The Company is working with researchers within the USAF to land and expand, connecting different groups and finding new stakeholders that can benefit from our A.I. offering. The Air Force Research Laboratory’s Airman Systems Directorate is a vital component of the 711th Human Performance Wing. The directorate is composed of a diverse group of scientists and engineers studying developing technologies specific to the human element of warfighting capability.

The Air Force Research Laboratory (“AFRL”) is leading the discovery, development, and integration of affordable warfighting technologies for the U.S. Air and Space Force. AFRL is a scientific research organization operated by the United States Air Force Materiel Command dedicated to leading the discovery, development, and integrate biological and cognitive technologies to optimize and protect integration of affordable aerospace warfighting technologies, planning and executing the Air Force science and technology program, and providing warfighting capabilities to United States air, space, and cyberspace forces.

For more information on this project or to learn how Datametrex can assist your organization in social media discovery, Fake News Filters and BOT detection, please go to www.nexalogy.com

About Datametrex

Datametrex AI Limited is a technology-focused company with exposure to Artificial Intelligence and Machine Learning through its wholly owned subsidiary, Nexalogy (www.nexalogy.com). Datametrex’s mission is to provide tools that support companies in fulfilling their operational Health and Safety goals with predictive and preventive technologies. By working with companies to set a new standard of protocols through Artificial Intelligence and health diagnostics, the Company provides progressive solutions to support the supply chain.

Additional information on Datametrex is available at www.datametrex.com

For further information, please contact:

Marshall Gunter – CEO
Phone: (514) 295-2300
Email: [email protected]

Neither the TSX Venture Exchange nor it’s Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Forward-Looking Statements

This news release contains “forward-looking information” within the meaning of applicable securities laws. All statements contained herein that are not clearly historical in nature may constitute forward-looking information. In some cases, forward-looking information can be identified by words or phrases such as “may”, “will”, “expect”, “likely”, “should”, “would”, “plan”, “anticipate”, “intend”, “potential”, “proposed”, “estimate”, “believe” or the negative of these terms, or other similar words, expressions and grammatical variations thereof, or statements that certain events or conditions “may” or “will” happen, or by discussions of strategy.

Readers are cautioned to consider these and other factors, uncertainties and potential events carefully and not to put undue reliance on forward-looking information. The forward-looking information contained herein is made as of the date of this press release and is based on the beliefs, estimates, expectations and opinions of management on the date such forward-looking information is made. The Company undertakes no obligation to update or revise any forward-looking information, whether as a result of new information, estimates or opinions, future events or results or otherwise or to explain any material difference between subsequent actual events and such forward-looking information, except as required by applicable law.

Datametrex #DM.ca Initiates #OTCQB Application

Posted by AGORACOM-JC at 9:59 AM on Thursday, July 30th, 2020
  • Commenced the process to have the Company’s common shares upgraded and quoted on the OTCQB® Market exchange in the United States
  • Company’s Canadian legal counsel, McMillan LLP, will be acting as Principal American Liaison (“PAL”) in assisting the Company through the U.S. listing application process. Subject to fulfilling various regulatory requirements and completion of due diligence, the Company believes the process should take no more than three months

TORONTO, July 30, 2020 — Datametrex AI Limited (“Datametrex” or the “Company“) (TSXV: DM, FSE: D4G, OTC: DTMXF) announces that it has commenced the process to have the Company’s common shares upgraded and quoted on the OTCQB® Market exchange in the United States.

The Company’s Canadian legal counsel, McMillan LLP, will be acting as Principal American Liaison (“PAL”) in assisting the Company through the U.S. listing application process. Subject to fulfilling various regulatory requirements and completion of due diligence, the Company believes the process should take no more than three months.

Moving to the OTCQB® in the United States will provide existing shareholders with an additional trading platform to the TSX Venture Exchange in addition to introducing the Company to a broader range of retail and institutional investors that a U.S. listing provides.

Listing Datametrex on the OTCQB® represents a first step in fulfilling the Company’s ambitions to list on a U.S. stock exchange such as NASDAQ and NYSE.

About OTC Markets Group Inc.

OTC Markets Group Inc. (OTCQX:OTCM) operates Open, Transparent and Connected financial marketplaces for 10,000 U.S. and global securities. Through our OTC Link® ATS, we directly link a diverse network of broker-dealers that provide liquidity and execution services for a wide spectrum of securities. We organize these securities into marketplaces to better inform investors of opportunities and risks – OTCQX® – The Intelligent Marketplace for the Best OTC Companies; OTCQB® – The Venture Marketplace; and OTC Pink® – The Open Marketplace. Our data-driven platform enables investors to easily trade through the broker of their choice at the best possible price and empowers a broad range of companies to improve the quality and availability of information for their investors. To learn more about how we create better informed and more efficient financial marketplaces, visit www.otcmarkets.com.

About Datametrex

Datametrex AI Limited is a technology focused company with exposure to Artificial Intelligence and Machine Learning through its wholly owned subsidiary, Nexalogy (www.nexalogy.com). Datametrex’s mission is to provide tools that support companies in fulfilling their operational goals, including Health and Safety, with predictive and preventive technologies. By working with companies to set a new standard of protocols through Artificial Intelligence and health diagnostics, the Company provides progressive solutions to support the supply chain. Additional information on Datametrex is available at www.datametrex.com

For further information, please contact:

Marshall Gunter – CEO
Phone: (514) 295-2300
Email: [email protected]

Neither the TSX Venture Exchange nor it’s Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Forward-Looking Statements

This news release contains “forward-looking information” within the meaning of applicable securities laws.  All statements contained herein that are not clearly historical in nature may constitute forward-looking information. In some cases, forward-looking information can be identified by words or phrases such as “may”, “will”, “expect”, “likely”, “should”, “would”, “plan”, “anticipate”, “intend”, “potential”, “proposed”, “estimate”, “believe” or the negative of these terms, or other similar words, expressions and grammatical variations thereof, or statements that certain events or conditions “may” or “will” happen, or by discussions of strategy. Readers are cautioned to consider these and other factors, uncertainties and potential events carefully and not to put undue reliance on forward-looking information. The forward-looking information contained herein is made as of the date of this press release and is based on the beliefs, estimates, expectations and opinions of management on the date such forward-looking information is made. The Company undertakes no obligation to update or revise any forward-looking information, whether as a result of new information, estimates or opinions, future events or results or otherwise or to explain any material difference between subsequent actual events and such forward-looking information, except as required by applicable law.

Datametrex $DM.ca Appoints Hon. James S. Peterson, P.C.

Posted by AGORACOM-JC at 11:01 AM on Tuesday, July 28th, 2020
  • Announced the appointment of Hon. James S. Peterson, P.C., as a new independent member of the Board of Directors
  • Hon. Peterson is a former federal Cabinet Minister and Secretary of State, with extensive knowledge and first-hand experience legal, financial, board governance and government affairs

TORONTO, July 28, 2020 – Datametrex AI Limited (the “Company” or “Datametrex”) (TSXV: DM, FSE: D4G, OTC: DTMXF) is pleased to announce the appointment of Hon. James S. Peterson, P.C., as a new independent member of the Board of Directors. Hon. Peterson is a former federal Cabinet Minister and Secretary of State, with extensive knowledge and first-hand experience legal, financial, board governance and government affairs.

“I want to thank our newest Board Member for taking on the position of Director at Datametrex,” said CEO, Marshall Gunter. “His diplomacy and global business acumen are critical assets to better position us in the market, so that we can operate at the highest level in this changing environment. We continue striving for increased collaboration with new consortia in the preventive technologies industries around the world.”

Jim Peterson with his government experience on the world stage brings a wealth of knowledge in strategic planning and government affairs. He will be using this experience in helping Datametrex engage with world governments to bring more testing to the general population to eradicate the spread of the COVID-19 virus. 

Jim obtained his BA and LLB from Western University, his LLM from Columbia University and his DCL from McGill University. He also taught Law at University of Toronto, and worked for the UN International development organization in Vienna, Khartoum, and Kuala Lumpur on International joint business ventures in developing countries. He is a Member of the Ontario Bar Association, the Canadian Bar Association, and is a Co-Chair of the Canada-US Law Institute. Jim has also served for the Government of Canada as Minister of International Trade, Secretary of State (International Financial Institutions), and Chair of the House of Commons Standing Committee on Finance. While a Cabinet Minister, Jim represented Canada at the World Trade Organization’s Doha round of negotiations, which were focused on expanding trade and investment in leading emerging markets Brazil, Russia, India and China, and with complex issues related to trade with Canada’s NAFTA partners, the European Union, the Middle East and the Americas.

Jim served as Chair of the House of Commons Finance Committee where he began the practice of public pre-budget hearings and completed several major studies including a review of Canada’s value added tax (the GST). He retired from the House of Commons in 2007 after 23 years of public service as the Member of Parliament for Willowdale (Toronto).

“I am a firm believer that time is a resource that companies in high-growth mode cannot afford to waste,” Hon. Peterson said. “Datametrex is certainly among those companies. I am honoured to join the Board of this thriving Company; I look forward to further contribute to the strong innovative systems that make a difference in our society.”

The company has issued Jim 1,000,000 options.

As part of the Board changes, the Company announces that David Ellison is stepping down from the Board of Directors to make room for Jim, and will be joining the Advisory Board to continue supporting Datametrex with his legal expertise. Datametrex thanks David for his efforts and for still serving Datametrex to help solve the Company’s most pressing challenges.

About Datametrex

Datametrex AI Limited is a technology-focused with exposure to Artificial Intelligence and Machine Learning through its wholly-owned subsidiary, Nexalogy (www.nexalogy.com). Datametrex’s mission is to provide tools that support companies in fulfilling their operational goals, including Health and Safety, with predictive and preventive technologies. By working with companies to set a new standard of protocols through Artificial Intelligence and health diagnostics, Company provides progressive solutions to support the supply chain. Additional information on Datametrex is available at www.datametrex.com.

For further information, please contact:
Marshall Gunter – CEO
Phone: (514) 295-2300
Email:  [email protected]

Neither the TSX Venture Exchange nor it’s Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Forward-Looking Statements
This news release contains “forward-looking information” within the meaning of applicable securities laws.  All statements contained herein that are not historical in nature may constitute forward-looking information. In some cases, forward-looking information can be identified by words or phrases such as “may”, “will”, “expect”, “likely”, “should”, “would”, “plan”, “anticipate”, “intend”, “potential”, “proposed”, “estimate”, “believe” or the negative of these terms, or other similar words, expressions and grammatical variations thereof, or statements that certain events or conditions “may” or “will” happen, or by discussions of strategy. Readers are cautioned to consider these and other factors, uncertainties and potential events carefully and not to put undue reliance on forward-looking information. The forward-looking information contained herein is made as of the date of this press release and is based on the beliefs, estimates, expectations and opinions of management on the time such forward-looking information is made. Company undertakes no obligation to update or revise any forward-looking information, whether as a result of new information, estimates or opinions, future events or results or otherwise or to explain any material difference between subsequent actual events and such forward-looking information, except as required by applicable law.